NDC-026 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

6,325 results for “NDC-026”

Trials

View all 3049 →

OMNEON-026

0 participants

Multiple Dose Study to Evaluate Drug-drug Interactions, Safety and Tolerability of NDC-002 in Healthy Volunteers

33 participants · First posted Oct 19, 2023

Quasi-Randomized Evaluation of the UCLA Next Day Clinic (NDC)

570 participants · First posted Jul 30, 2024

Drugs

View all 1918 →

NDC-002

NDC-1308

NDC-1187

Organizations

View all 26 →

Ndc Inc

United States

CANTARGIA AB

Sweden

NEODYNE BIOSCIENCES, INC.

United States

News

View all 1332 →

DR.NOAH Biotech's AI-Driven ALS Drug, NDC-011, Receives FDA Approval for Phase 1 Trial

XORTX Advances Gout Program with FDA Discussions for XRx-026

Phoenix Molecular Designs Initiates Phase 2 Trial of PMD-026 Combination Therapy for Advanced Breast Cancer

Page 1 of 633